e-learning
resources
Virtual 2021
07.09.2021
Advances in asthma treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of Asthma control and oral corticosteroids in Severe Asthma
C. Micheletto (Verona, Italy), M. Bilò (Ancona, Italy), L. Antonicelli (Ancona, Italy), F. De Michele (Napoli, Italy), A. Musarra (Reggio Calabria, Italy), A. Vagni (Garbagnate Milanese (MI), Italy)
Source:
Virtual Congress 2021 – Advances in asthma treatment
Session:
Advances in asthma treatment
Session type:
E-poster
Number:
3529
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Micheletto (Verona, Italy), M. Bilò (Ancona, Italy), L. Antonicelli (Ancona, Italy), F. De Michele (Napoli, Italy), A. Musarra (Reggio Calabria, Italy), A. Vagni (Garbagnate Milanese (MI), Italy). Evaluation of Asthma control and oral corticosteroids in Severe Asthma. 3529
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Chronic oral corticosteroids use and persistent eosinophilia in severe asthma. The Belgian Severe Asthma Registry.
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Effect of oral corticosteroids on symptomatic reflux in severe allergic asthma: Is there a link?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Evaluation of methotrexate in the treatment of severe asthma
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Long-acting beta2 agonist without concomitant inhaled corticosteroids in children with asthma in primary care
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
When needed use of inhaled steroids in children with asthma
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
The effect of Corticophobia on Inhaled Corticosteroid Treatment Compliance In Adults with Asthma
Source: International Congress 2018 – Asthma analysis
Year: 2018
Safety and Efficacy of Omalizumab in Elderly Patients with Uncontrolled Allergic Asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014
Adherence with inhaled corticosteroids in asthma: Does pregnancy lead to improved adherence?
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
Allergic rhinitis does it have an impact on controller asthma therapy choice
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Experience with omalizumab in patients with moderate and severe asthma
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014
FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014
Cost Effectiveness Of Bronchial Thermoplasty For Treatment Of Severe Asthma Patients In Scotland
Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Year: 2017
Assessment of Efficacy Omalizumab Retreatment in Patients With Severe Asthma
Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures
Year: 2018
Assessment of mis-beliefs about bronchial asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Efficacy and safety of fluticasone propionate/formoterol in paediatric patients with asthma
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Metered-dose inhaler albuterol: Evaluation of efficacy and safety of increasing doses in children with acute wheezing
Source: International Congress 2014 – Paediatric asthma: lung function testing and more
Year: 2014
Clinical effectiveness of anti-IgE therapy in severe asthma with fungus sensitization
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Asthma
Source: Eur Respir Monogr 2017; 77: 1-12
Year: 2017
Asthma
Source: Eur Respir Monogr 2013; 62: 19-36
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept